Bertici, N.S.; Cut, T.G.; Ridichie, A.; Manzur, A.R.; Bertici, R.A.
Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection—Case Report and Literature Review. Int. J. Mol. Sci. 2025, 26, 8117.
https://doi.org/10.3390/ijms26178117
AMA Style
Bertici NS, Cut TG, Ridichie A, Manzur AR, Bertici RA.
Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection—Case Report and Literature Review. International Journal of Molecular Sciences. 2025; 26(17):8117.
https://doi.org/10.3390/ijms26178117
Chicago/Turabian Style
Bertici, Nicoleta Sorina, Talida Georgiana Cut, Amalia Ridichie, Andrei Raul Manzur, and Razvan Adrian Bertici.
2025. "Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection—Case Report and Literature Review" International Journal of Molecular Sciences 26, no. 17: 8117.
https://doi.org/10.3390/ijms26178117
APA Style
Bertici, N. S., Cut, T. G., Ridichie, A., Manzur, A. R., & Bertici, R. A.
(2025). Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection—Case Report and Literature Review. International Journal of Molecular Sciences, 26(17), 8117.
https://doi.org/10.3390/ijms26178117
